Prof. Dr. Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award
CONICET | Argentina
Dr. Néstor Horacio García, MD, PhD, is a physician-scientist specializing in nephrology and vascular research with a strong focus on renal physiology, hypertension, and phosphate homeostasis. He earned his medical and doctoral degrees from the National University of Córdoba, complemented by advanced research training at the Henry Ford Hospital in the United States, where he investigated mechanisms related to hypertension and vascular regulation. His postdoctoral fellowship at the Mayo Foundation in Rochester, Minnesota, further deepened his expertise in phosphate metabolism and kidney function. Dr. García has served as a Research Clinical Associate in the Nephrology Department at Sanatorium Mayo, Córdoba, where he has acted as Principal Investigator for multiple pharmaceutical protocols and clinical studies. He has also contributed to Inspiranox Therapeutics Corporation as a medical scientist and clinical research consultant, engaging in translational and therapeutic innovation. His research explores the pathophysiology of kidney disease, the molecular regulation of blood pressure, and protective mechanisms against diabetic renal dysfunction. Recognized nationally and internationally, Dr. García has received multiple awards for excellence in basic nephrology research, including honors from the Argentine Society of Hypertension and the Latin American Society of Nephrology and Hypertension (SLANH).
Profile: Orcid
Featured Publications:
García, N. H. (2021). An intensive follow-up in subjects with cardiometabolic high-risk. Nutrition, Metabolism and Cardiovascular Diseases.
García, N. H. (2021). Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease. Stroke, 52(5), e125–e132.
García, N. H. (2020). Monosialoganglioside GM1 reduces toxicity of Ptx and increases anti-metastatic effect in a murine mammary cancer model. Scientific Reports, 10(1), 10645.
García, N. H. (2020). Ibuprofen, a traditional drug that may impact the course of COVID-19: New effective formulation in nebulizable solution. Medical Hypotheses, 144, 110079.
García, N. H. (2020). Eicosapentaenoic acid prevents salt sensitivity in diabetic rats and decreases oxidative stress. Nutrition, 79–80, 110644.
